Clinical Trial Update: Lobaplation or Cisplatin in Adjuvant Chemotherapy for Esophageal Carcinoma [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing lobaplatin or cisplatin in adjuvant chemotherapy for esophageal cancer completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Lobaplatin (lobaplatin)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Esophageal Cancer | Phase 4 | Status: COMPLETED